| P2093 | author name string | Brian D Lichty | |
| | Zhou Xing | |
| P2860 | cites work | Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98 | Q28139522 |
| | The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes | Q33605916 |
| | Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge | Q33783986 |
| | Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies | Q33804540 |
| | Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development | Q33842546 |
| | Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses | Q33987611 |
| | Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature | Q34048678 |
| | Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis | Q34122078 |
| | TB vaccines: progress and problems. | Q34207642 |
| | VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents | Q34273164 |
| | Recombinant vesicular stomatitis viruses from DNA. | Q34337129 |
| | Adenoviruses as vaccine vectors | Q34353523 |
| | Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans | Q34361636 |
| | Gene therapy progress and prospects: adenoviral vectors | Q35165719 |
| | Tuberculosis vaccines: the past, present and future | Q35193467 |
| | Vesicular stomatitis virus: re-inventing the bullet | Q35761892 |
| | Tuberculosis vaccine development: research, regulatory and clinical strategies | Q35873788 |
| | Adenoviral vectors for mucosal vaccination against infectious diseases. | Q36202961 |
| | Multiple vesiculoviral matrix proteins inhibit both nuclear export and import | Q37106762 |
| | Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung | Q37370914 |
| | Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs | Q38447094 |
| | Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions | Q39761202 |
| | Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. | Q39982362 |
| | Detailed analysis of the CD8+ T-cell response following adenovirus vaccination | Q40344509 |
| | Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine | Q40393493 |
| | The use of adenoviral vectors for gene therapy and gene transfer in vivo | Q40425311 |
| | Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation. | Q40977476 |
| | Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG | Q41908519 |
| | Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis | Q44681127 |
| | Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis | Q45231616 |
| | Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara | Q45722508 |
| | An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants | Q45735721 |
| | Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia | Q45881120 |
| | Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen | Q47783342 |
| | Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation | Q64381978 |
| | TB vaccines for the World | Q81352716 |
| P433 | issue | 3-4 | |
| P921 | main subject | immunization | Q1415366 |
| | tuberculosis | Q12204 |
| | vector-borne disease | Q2083837 |
| P304 | page(s) | 211-217 | |
| P577 | publication date | 2006-02-28 | |
| P1433 | published in | Tuberculosis | Q15757844 |
| P1476 | title | Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization | |
| P478 | volume | 86 | |